TY  - JOUR
AU  - Alonso González, Mario
AU  - Quispe Chauca, Prissila
AU  - Fernández Carballido, Ana María
AU  - Lozza, Irene
AU  - Martín Sabroso, Cristina
AU  - Fraguas Sánchez, Ana Isabel
PY  - 2022
DO  - 10.1016/j.ejpb.2022.09.022
SN  - 0939-6411
UR  - https://hdl.handle.net/20.500.14352/72578
T2  - European Journal of Pharmaceutics and Biopharmaceutics
AB  - Abnormal angiogenesis plays a main role in the pathogenesis of many diseases such as cancer, and inflammatory autoimmune disorders among others, and its inhibition represents a potential strategy for their management. Celecoxib (CXB) that is one of...
LA  - eng
M2  - 149
PB  - Elsevier
KW  - Angiogenesis
KW  - COX-2 inhibitors
KW  - Inflammation
KW  - Nanomedicine
KW  - Plackett-Burman design
KW  - Polymeric nanoparticles
KW  - Yolk sac model (YSM
TI  - DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect
TY  - journal article
VL  - 180
ER  -